Sylvain Lehmann

22.4k total citations · 4 hit papers
340 papers, 13.7k citations indexed

About

Sylvain Lehmann is a scholar working on Molecular Biology, Physiology and Neurology. According to data from OpenAlex, Sylvain Lehmann has authored 340 papers receiving a total of 13.7k indexed citations (citations by other indexed papers that have themselves been cited), including 196 papers in Molecular Biology, 83 papers in Physiology and 56 papers in Neurology. Recurrent topics in Sylvain Lehmann's work include Prion Diseases and Protein Misfolding (97 papers), Alzheimer's disease research and treatments (69 papers) and Neurological diseases and metabolism (43 papers). Sylvain Lehmann is often cited by papers focused on Prion Diseases and Protein Misfolding (97 papers), Alzheimer's disease research and treatments (69 papers) and Neurological diseases and metabolism (43 papers). Sylvain Lehmann collaborates with scholars based in France, United States and Spain. Sylvain Lehmann's co-authors include David A. Harris, Christophe Hirtz, Audrey Gabelle, Alain Mangé, Jacques Grassi, Krista L. Moulder, Show‐Ling Shyng, Ollivier Milhavet, Carole Crozet and Jérôme Vialaret and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Sylvain Lehmann

328 papers receiving 13.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry

2008 683 citations Gunnar Juliusson, Petar Antunović et al. Blood profile →
Signal Transduction Through Prion Protein

2000 633 citations Jean Laplanche, Sylvain Lehmann et al. profile →
Sulfated Glycans Stimulate Endocytosis of the Cellular Isoform of the Prion Protein, PrPC, in Cultured Cells

1995 607 citations Sylvain Lehmann et al. profile →
Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease

2019 345 citations Sylvain Lehmann et al. Alzheimer s Research & Therapy profile →

Peers

Countries citing papers authored by Sylvain Lehmann

Since Specialization

Citations

This map shows the geographic impact of Sylvain Lehmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvain Lehmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvain Lehmann more than expected).

Fields of papers citing papers by Sylvain Lehmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvain Lehmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvain Lehmann. The network helps show where Sylvain Lehmann may publish in the future.

Co-authorship network of co-authors of Sylvain Lehmann

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvain Lehmann. A scholar is included among the top collaborators of Sylvain Lehmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvain Lehmann. Sylvain Lehmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A French multicenter analytical evaluation of the automated Lumipulse G sNfL blood assay (Fujirebio®) and its comparison to four other immunoassays for serum neurofilament light chain assessment in clinical settings 2024 ·Clinica Chimica Acta ·(unknown), Susanna Schraen‐Maschke, Isabelle Quadrio, Olivier Bousiges, Damien Bouvier, Constance Delaby, Aurélie Bedel, Sylvain Lehmann, Anthony Fourier	2
2	Delineating functional and molecular impact of ex vivo sample handling in precision medicine 2024 ·npj Precision Oncology ·(unknown), (unknown), Mattias Vesterlund, (unknown), Tojo James, (unknown), Georgios Mermelekas, (unknown), (unknown), Sofia Bengtzén, Rozbeh Jafari, Lukas M. Orre, Janne Lehtiö, Sylvain Lehmann, Päivi Östling, Olli Kallioniemi, Brinton Seashore‐Ludlow, Tom Erkers	2
3	TWEAK and TNFɑ Pro-inflammatory Soluble Cytokines and their Specific Autoantibodies Secretion in Multiple Sclerosis Patients 2024 ·Inflammation ·Sylvie Carmona, (unknown), Thierry Vincent, Pierre Labauge, Clarisse Carra‐Dallière, Sylvain Lehmann, Sophie Desplat‐Jégo, Xavier Ayrignac	0
4	Clinical value of plasma ALZpath pTau217 immunoassay for assessing mild cognitive impairment 2024 ·Journal of Neurology Neurosurgery & Psychiatry ·Sylvain Lehmann, Susanna Schraen‐Maschke, Jean‐Sébastien Vidal, Constance Delaby, Luc Buée, ‪Frederic Blanc‬, Claire Paquet, Bernadette Allinquant, Stéphanie Bombois, Audrey Gabelle, Olivier Hanon	20
5	CD138 as a Specific CSF Biomarker of Multiple Sclerosis 2024 ·Neurology Neuroimmunology & Neuroinflammation ·(unknown), (unknown), Serge Urbach, Nicolas Salvetat, (unknown), (unknown), Chantal Ripoll, Renaud Cezar, Sabine Laurent‐Chabalier, Christophe Dematteï, Hanane Agherbi, Giovanni Castelnovo, Sylvain Lehmann, Valérie Rigau, Philippe Marin, Éric Thouvenot	4
6	Blood Neurofilament Levels Predict Cognitive Decline across the Alzheimer’s Disease Continuum 2023 ·International Journal of Molecular Sciences ·Sylvain Lehmann, Susanna Schraen‐Maschke, Jean‐Sébastien Vidal, Frédéric Blanc, Claire Paquet, Bernadette Allinquant, Stéphanie Bombois, Audrey Gabelle, Constance Delaby, Olivier Hanon	12
7	Neurofilament-Light, a Promising Biomarker: Analytical, Metrological and Clinical Challenges 2023 ·International Journal of Molecular Sciences ·(unknown), Sylvain Lehmann, (unknown), Christophe Hirtz	40
8	Plasma phosphorylated tau 181 predicts amyloid status and conversion to dementia stage dependent on renal function 2023 ·Journal of Neurology Neurosurgery & Psychiatry ·Sylvain Lehmann, Susanna Schraen‐Maschke, Jean‐Sébastien Vidal, Constance Delaby, Frédéric Blanc, Claire Paquet, Bernadette Allinquant, Stéphanie Bombois, Audrey Gabelle, Olivier Hanon	32
9	Serum neurofilament light chain cut‐off definition for clinical diagnosis and prognosis of amyotrophic lateral sclerosis 2023 ·European Journal of Neurology ·(unknown), Constance Delaby, Elisa De La Cruz, Jens Kühle, Pascal Benkert, (unknown), (unknown), Christophe Hirtz, William Camu, Sylvain Lehmann, Florence Esselin	10
10	Lifelong exposure to high‐altitude hypoxia in humans is associated with improved redox homeostasis and structural–functional adaptations of the neurovascular unit 2023 ·The Journal of Physiology ·Benjamin S. Stacey, Ryan L. Hoiland, Hannah G. Caldwell, Connor A. Howe, (unknown), Michael M. Tymko, Gustavo Vizcardo‐Galindo, (unknown), Rómulo Figueroa‐Mujíca, Christopher Gasho, Édouard Tuaillon, Christophe Hirtz, Sylvain Lehmann, Nicola Marchi, Hayato Tsukamoto, Francisco C. Villafuerte, Philip N. Ainslie, Damian M. Bailey	14
11	Use of dried blood spots for monitoring inflammatory and nutritional biomarkers in the elderly 2023 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Jérôme Vialaret, (unknown), Christophe Hirtz, Stéphanie Badiou, (unknown), (unknown), Anne‐Marie Dupuy, Aleksandra Maleska Maceski, (unknown), (unknown), Jean‐Paul Cristol, Claude Jeandel, Sylvain Lehmann	5
12	Development of a candidate reference measurement procedure by ID-LC-MS/MS for total tau protein measurement in cerebrospinal fluid (CSF) 2023 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Chiara Giangrande, (unknown), Amandine Bœuf, Béatrice Lalère, Christophe Hirtz, Sylvain Lehmann, Milena Quaglia, Vincent Delatour	8
13	Deciphering Black Extrinsic Tooth Stain Composition in Children Using Metaproteomics 2022 ·ACS Omega ·Christophe Hirtz, (unknown), (unknown), Olivier Pible, (unknown), Jean Armengaud, (unknown), (unknown), (unknown), (unknown), Catherine Dunyach‐Remy, Laurent Tiers, Jean‐Philippe Lavigne, Paul Tramini, (unknown), Sylvain Lehmann, Dominique Deville de Périère, Jérôme Vialaret	7
14	Cerebrospinal fluid A beta 1–40 peptides increase in Alzheimer’s disease and are highly correlated with phospho-tau in control individuals 2020 ·Alzheimer s Research & Therapy ·Sylvain Lehmann, Julien Dumurgier, Xavier Ayrignac, Cécilia Marelli, Daniel Alcolea, Juan Fortea, Éric Thouvenot, Constance Delaby, Christophe Hirtz, Jérôme Vialaret, (unknown), Élodie Bouaziz-Amar, Jean Laplanche, Pierre Labauge, Claire Paquet, Alberto Lleó, Audrey Gabelle, (unknown)	40
15	Proteomic Identification of Allergenic Proteins of Morus alba L. Pollen 2018 ·Asian Pacific Journal of Allergy and Immunology ·(unknown), (unknown), Aslı Gelincik, Sylvie Michelland, Evren Önay Uçar, (unknown), Nilgün Akdeniz, (unknown), (unknown), Ünal Akkemık, Günnur Deniz, Murat Pekmez, (unknown), Sylvain Lehmann, Sandrine Bourgoin‐Voillard, Michel Sève, Suna Büyüköztürk, Nazlı Arda	2
16	Staurosporine resistance in inflammatory neutrophils is associated with the inhibition of caspase- and proteasome-mediated Mcl-1 degradation 2015 ·Journal of Leukocyte Biology ·(unknown), Sylvain Lehmann, (unknown), (unknown), Michèle J. Hoffmann, Christoph Peter, Sebastian Wesselborg, Klaus Unfried, Joachim Windolf, Sascha Flohé, Adnana Paunel‐Görgülü	11
17	Analysis of the DNA methylome and transcriptome in granulopoiesis reveals timed changes and dynamic enhancer methylation 2014 ·Blood ·Michelle Rönnerblad, Robin Andersson, Tor Olofsson, Iyadh Douagi, Mohsen Karimi, Sylvain Lehmann, Ilka Hoof, Michiel de Hoon, Masayoshi Itoh, Sayaka Nagao-Sato, Hideya Kawaji, Timo Lassmann, Piero Carninci, Yoshihide Hayashizaki, Alistair R. R. Forrest, Albin Sandelin, Karl Ekwall, Peter Arner, Andreas Lennartsson	60
18	Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry breakdown → 2008 ·Blood ·Gunnar Juliusson, Petar Antunović, Åsa Rangert Derolf, Sylvain Lehmann, Lars Möllgård, Dick Stockelberg, Ulf Tidefelt, Anders Wåhlin, Martin Höglund	683
19	Techniques in Prion Research 2004 ·Birkhäuser Basel eBooks ·Sylvain Lehmann, Jacques Grassi	44
20	X-linked adrenal hypoplasia congenita is caused by abnormal nuclear localization of the DAX-1 protein 2002 ·Proceedings of the National Academy of Sciences ·Sylvain Lehmann, Enzo Lalli, Paolo Sassone‐Corsi	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact